The younger the antidepressant user, the more likely they are to have suicidal thoughts. That’s the conclusion the Food and Drug Administration (FDA) had after they researched 372 clinical studies involving 11 antidepressants to see if increased suicidal thoughts and behavior in children continued through to adulthood. The study involved over 100,000 patients and dated back to 1985.
The FDA determined that the risk of suicide was greater with younger patients and continued to decline with age. Those 65 and older were the least likely to have suicidal tendencies. Paxil, Zoloft and Prozac were among the antidepressants used in the studies.
Currently, antidepressants have a “black box” warning about the increased risk in children and young adults. The FDA will decide with the help of an advisory panel if the labels need to be updated to include suicidal thinking in adults.